 | • レポートコード：QY2207E01383 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,102,500 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のレボシメンダンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にレボシメンダンの世界市場のxxx％を占める「純度≥99.5％」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「注射液」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のレボシメンダンの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのレボシメンダン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのレボシメンダン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 レボシメンダンのグローバル主要メーカーには、Tenax Therapeutics、Shengnuo Biotechnology、Olon、Melody Healthcare、Precise Group、Alven Laboratories、Fermion、Aspen、Enomark、Sirnaomicsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 レボシメンダン市場は、種類と用途によって区分されます。世界のレボシメンダン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 純度≥99.5％、純度≥99.9％ 【用途別セグメント】 注射液、経口液 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - レボシメンダン製品概要 - 種類別市場（純度≥99.5％、純度≥99.9％） - 用途別市場（注射液、経口液） - 調査の目的 ・エグゼクティブサマリー - 世界のレボシメンダン販売量予測2017-2028 - 世界のレボシメンダン売上予測2017-2028 - レボシメンダンの地域別販売量 - レボシメンダンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別レボシメンダン販売量 - 主要メーカー別レボシメンダン売上 - 主要メーカー別レボシメンダン価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（純度≥99.5％、純度≥99.9％） - レボシメンダンの種類別販売量 - レボシメンダンの種類別売上 - レボシメンダンの種類別価格 ・用途別市場規模（注射液、経口液） - レボシメンダンの用途別販売量 - レボシメンダンの用途別売上 - レボシメンダンの用途別価格 ・北米市場 - 北米のレボシメンダン市場規模（種類別、用途別） - 主要国別のレボシメンダン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのレボシメンダン市場規模（種類別、用途別） - 主要国別のレボシメンダン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のレボシメンダン市場規模（種類別、用途別） - 主要国別のレボシメンダン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のレボシメンダン市場規模（種類別、用途別） - 主要国別のレボシメンダン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのレボシメンダン市場規模（種類別、用途別） - 主要国別のレボシメンダン市場規模（トルコ、サウジアラビア） ・企業情報 Tenax Therapeutics、Shengnuo Biotechnology、Olon、Melody Healthcare、Precise Group、Alven Laboratories、Fermion、Aspen、Enomark、Sirnaomics ・産業チェーン及び販売チャネル分析 - レボシメンダンの産業チェーン分析 - レボシメンダンの原材料 - レボシメンダンの生産プロセス - レボシメンダンの販売及びマーケティング - レボシメンダンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - レボシメンダンの産業動向 - レボシメンダンのマーケットドライバー - レボシメンダンの課題 - レボシメンダンの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Levosimendan Market
Due to the COVID-19 pandemic, the global Levosimendan market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99.5% accounting for % of the Levosimendan global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Injection Solution segment is altered to an % CAGR throughout this forecast period.
China Levosimendan market size is valued at US$ million in 2021, while the US and Europe Levosimendan are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Levosimendan landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Levosimendan include Tenax Therapeutics, Shengnuo Biotechnology, Olon, Melody Healthcare, Precise Group, Alven Laboratories, Fermion, Aspen and Enomark and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Levosimendan capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Levosimendan by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Levosimendan Scope and Segment
Levosimendan market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Levosimendan market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity ≥99.5%
Purity ≥99.9%
Segment by Application
Injection Solution
Oral Liquid
By Company
Tenax Therapeutics
Shengnuo Biotechnology
Olon
Melody Healthcare
Precise Group
Alven Laboratories
Fermion
Aspen
Enomark
Sirnaomics
Production by Region
North America
Europe
China
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Levosimendan Product Introduction
1.2 Market by Type
1.2.1 Global Levosimendan Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ≥99.5%
1.2.3 Purity ≥99.9%
1.3 Market by Application
1.3.1 Global Levosimendan Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Injection Solution
1.3.3 Oral Liquid
1.4 Study Objectives
1.5 Years Considered
2 Global Levosimendan Production
2.1 Global Levosimendan Production Capacity (2017-2028)
2.2 Global Levosimendan Production by Region: 2017 VS 2021 VS 2028
2.3 Global Levosimendan Production by Region
2.3.1 Global Levosimendan Historic Production by Region (2017-2022)
2.3.2 Global Levosimendan Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 India
3 Global Levosimendan Sales in Volume & Value Estimates and Forecasts
3.1 Global Levosimendan Sales Estimates and Forecasts 2017-2028
3.2 Global Levosimendan Revenue Estimates and Forecasts 2017-2028
3.3 Global Levosimendan Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Levosimendan Sales by Region
3.4.1 Global Levosimendan Sales by Region (2017-2022)
3.4.2 Global Sales Levosimendan by Region (2023-2028)
3.5 Global Levosimendan Revenue by Region
3.5.1 Global Levosimendan Revenue by Region (2017-2022)
3.5.2 Global Levosimendan Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Levosimendan Production Capacity by Manufacturers
4.2 Global Levosimendan Sales by Manufacturers
4.2.1 Global Levosimendan Sales by Manufacturers (2017-2022)
4.2.2 Global Levosimendan Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Levosimendan in 2021
4.3 Global Levosimendan Revenue by Manufacturers
4.3.1 Global Levosimendan Revenue by Manufacturers (2017-2022)
4.3.2 Global Levosimendan Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Levosimendan Revenue in 2021
4.4 Global Levosimendan Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Levosimendan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Levosimendan Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Levosimendan Sales by Type
5.1.1 Global Levosimendan Historical Sales by Type (2017-2022)
5.1.2 Global Levosimendan Forecasted Sales by Type (2023-2028)
5.1.3 Global Levosimendan Sales Market Share by Type (2017-2028)
5.2 Global Levosimendan Revenue by Type
5.2.1 Global Levosimendan Historical Revenue by Type (2017-2022)
5.2.2 Global Levosimendan Forecasted Revenue by Type (2023-2028)
5.2.3 Global Levosimendan Revenue Market Share by Type (2017-2028)
5.3 Global Levosimendan Price by Type
5.3.1 Global Levosimendan Price by Type (2017-2022)
5.3.2 Global Levosimendan Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Levosimendan Sales by Application
6.1.1 Global Levosimendan Historical Sales by Application (2017-2022)
6.1.2 Global Levosimendan Forecasted Sales by Application (2023-2028)
6.1.3 Global Levosimendan Sales Market Share by Application (2017-2028)
6.2 Global Levosimendan Revenue by Application
6.2.1 Global Levosimendan Historical Revenue by Application (2017-2022)
6.2.2 Global Levosimendan Forecasted Revenue by Application (2023-2028)
6.2.3 Global Levosimendan Revenue Market Share by Application (2017-2028)
6.3 Global Levosimendan Price by Application
6.3.1 Global Levosimendan Price by Application (2017-2022)
6.3.2 Global Levosimendan Price Forecast by Application (2023-2028)
7 North America
7.1 North America Levosimendan Market Size by Type
7.1.1 North America Levosimendan Sales by Type (2017-2028)
7.1.2 North America Levosimendan Revenue by Type (2017-2028)
7.2 North America Levosimendan Market Size by Application
7.2.1 North America Levosimendan Sales by Application (2017-2028)
7.2.2 North America Levosimendan Revenue by Application (2017-2028)
7.3 North America Levosimendan Sales by Country
7.3.1 North America Levosimendan Sales by Country (2017-2028)
7.3.2 North America Levosimendan Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Levosimendan Market Size by Type
8.1.1 Europe Levosimendan Sales by Type (2017-2028)
8.1.2 Europe Levosimendan Revenue by Type (2017-2028)
8.2 Europe Levosimendan Market Size by Application
8.2.1 Europe Levosimendan Sales by Application (2017-2028)
8.2.2 Europe Levosimendan Revenue by Application (2017-2028)
8.3 Europe Levosimendan Sales by Country
8.3.1 Europe Levosimendan Sales by Country (2017-2028)
8.3.2 Europe Levosimendan Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Levosimendan Market Size by Type
9.1.1 Asia Pacific Levosimendan Sales by Type (2017-2028)
9.1.2 Asia Pacific Levosimendan Revenue by Type (2017-2028)
9.2 Asia Pacific Levosimendan Market Size by Application
9.2.1 Asia Pacific Levosimendan Sales by Application (2017-2028)
9.2.2 Asia Pacific Levosimendan Revenue by Application (2017-2028)
9.3 Asia Pacific Levosimendan Sales by Region
9.3.1 Asia Pacific Levosimendan Sales by Region (2017-2028)
9.3.2 Asia Pacific Levosimendan Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Levosimendan Market Size by Type
10.1.1 Latin America Levosimendan Sales by Type (2017-2028)
10.1.2 Latin America Levosimendan Revenue by Type (2017-2028)
10.2 Latin America Levosimendan Market Size by Application
10.2.1 Latin America Levosimendan Sales by Application (2017-2028)
10.2.2 Latin America Levosimendan Revenue by Application (2017-2028)
10.3 Latin America Levosimendan Sales by Country
10.3.1 Latin America Levosimendan Sales by Country (2017-2028)
10.3.2 Latin America Levosimendan Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Levosimendan Market Size by Type
11.1.1 Middle East and Africa Levosimendan Sales by Type (2017-2028)
11.1.2 Middle East and Africa Levosimendan Revenue by Type (2017-2028)
11.2 Middle East and Africa Levosimendan Market Size by Application
11.2.1 Middle East and Africa Levosimendan Sales by Application (2017-2028)
11.2.2 Middle East and Africa Levosimendan Revenue by Application (2017-2028)
11.3 Middle East and Africa Levosimendan Sales by Country
11.3.1 Middle East and Africa Levosimendan Sales by Country (2017-2028)
11.3.2 Middle East and Africa Levosimendan Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Tenax Therapeutics
12.1.1 Tenax Therapeutics Corporation Information
12.1.2 Tenax Therapeutics Overview
12.1.3 Tenax Therapeutics Levosimendan Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Tenax Therapeutics Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Tenax Therapeutics Recent Developments
12.2 Shengnuo Biotechnology
12.2.1 Shengnuo Biotechnology Corporation Information
12.2.2 Shengnuo Biotechnology Overview
12.2.3 Shengnuo Biotechnology Levosimendan Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Shengnuo Biotechnology Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Shengnuo Biotechnology Recent Developments
12.3 Olon
12.3.1 Olon Corporation Information
12.3.2 Olon Overview
12.3.3 Olon Levosimendan Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Olon Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Olon Recent Developments
12.4 Melody Healthcare
12.4.1 Melody Healthcare Corporation Information
12.4.2 Melody Healthcare Overview
12.4.3 Melody Healthcare Levosimendan Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Melody Healthcare Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Melody Healthcare Recent Developments
12.5 Precise Group
12.5.1 Precise Group Corporation Information
12.5.2 Precise Group Overview
12.5.3 Precise Group Levosimendan Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Precise Group Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Precise Group Recent Developments
12.6 Alven Laboratories
12.6.1 Alven Laboratories Corporation Information
12.6.2 Alven Laboratories Overview
12.6.3 Alven Laboratories Levosimendan Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Alven Laboratories Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Alven Laboratories Recent Developments
12.7 Fermion
12.7.1 Fermion Corporation Information
12.7.2 Fermion Overview
12.7.3 Fermion Levosimendan Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Fermion Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Fermion Recent Developments
12.8 Aspen
12.8.1 Aspen Corporation Information
12.8.2 Aspen Overview
12.8.3 Aspen Levosimendan Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Aspen Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Aspen Recent Developments
12.9 Enomark
12.9.1 Enomark Corporation Information
12.9.2 Enomark Overview
12.9.3 Enomark Levosimendan Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Enomark Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Enomark Recent Developments
12.10 Sirnaomics
12.10.1 Sirnaomics Corporation Information
12.10.2 Sirnaomics Overview
12.10.3 Sirnaomics Levosimendan Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Sirnaomics Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Sirnaomics Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Levosimendan Industry Chain Analysis
13.2 Levosimendan Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Levosimendan Production Mode & Process
13.4 Levosimendan Sales and Marketing
13.4.1 Levosimendan Sales Channels
13.4.2 Levosimendan Distributors
13.5 Levosimendan Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Levosimendan Industry Trends
14.2 Levosimendan Market Drivers
14.3 Levosimendan Market Challenges
14.4 Levosimendan Market Restraints
15 Key Finding in The Global Levosimendan Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Levosimendan Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Purity ≥99.5%
Table 3. Major Manufacturers of Purity ≥99.9%
Table 4. Global Levosimendan Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Levosimendan Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 6. Global Levosimendan Production by Region (2017-2022) & (Tons)
Table 7. Global Levosimendan Production Market Share by Region (2017-2022)
Table 8. Global Levosimendan Production by Region (2023-2028) & (Tons)
Table 9. Global Levosimendan Production Market Share by Region (2023-2028)
Table 10. Global Levosimendan Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Levosimendan Sales by Region (2017-2022) & (Tons)
Table 12. Global Levosimendan Sales Market Share by Region (2017-2022)
Table 13. Global Levosimendan Sales by Region (2023-2028) & (Tons)
Table 14. Global Levosimendan Sales Market Share by Region (2023-2028)
Table 15. Global Levosimendan Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Levosimendan Revenue Market Share by Region (2017-2022)
Table 17. Global Levosimendan Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Levosimendan Revenue Market Share by Region (2023-2028)
Table 19. Global Levosimendan Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 20. Global Levosimendan Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Levosimendan Sales by Manufacturers (2017-2022) & (Tons)
Table 22. Global Levosimendan Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Levosimendan Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Levosimendan Revenue Share by Manufacturers (2017-2022)
Table 25. Levosimendan Price by Manufacturers 2017-2022 (US$/Ton)
Table 26. Global Levosimendan Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Levosimendan by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Levosimendan as of 2021)
Table 28. Levosimendan Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Levosimendan Product Offered
Table 30. Date of Manufacturers Enter into Levosimendan Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Levosimendan Sales by Type (2017-2022) & (Tons)
Table 33. Global Levosimendan Sales by Type (2023-2028) & (Tons)
Table 34. Global Levosimendan Sales Share by Type (2017-2022)
Table 35. Global Levosimendan Sales Share by Type (2023-2028)
Table 36. Global Levosimendan Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Levosimendan Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Levosimendan Revenue Share by Type (2017-2022)
Table 39. Global Levosimendan Revenue Share by Type (2023-2028)
Table 40. Levosimendan Price by Type (2017-2022) & (US$/Ton)
Table 41. Global Levosimendan Price Forecast by Type (2023-2028) & (US$/Ton)
Table 42. Global Levosimendan Sales by Application (2017-2022) & (Tons)
Table 43. Global Levosimendan Sales by Application (2023-2028) & (Tons)
Table 44. Global Levosimendan Sales Share by Application (2017-2022)
Table 45. Global Levosimendan Sales Share by Application (2023-2028)
Table 46. Global Levosimendan Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Levosimendan Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Levosimendan Revenue Share by Application (2017-2022)
Table 49. Global Levosimendan Revenue Share by Application (2023-2028)
Table 50. Levosimendan Price by Application (2017-2022) & (US$/Ton)
Table 51. Global Levosimendan Price Forecast by Application (2023-2028) & (US$/Ton)
Table 52. North America Levosimendan Sales by Type (2017-2022) & (Tons)
Table 53. North America Levosimendan Sales by Type (2023-2028) & (Tons)
Table 54. North America Levosimendan Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Levosimendan Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Levosimendan Sales by Application (2017-2022) & (Tons)
Table 57. North America Levosimendan Sales by Application (2023-2028) & (Tons)
Table 58. North America Levosimendan Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Levosimendan Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Levosimendan Sales by Country (2017-2022) & (Tons)
Table 61. North America Levosimendan Sales by Country (2023-2028) & (Tons)
Table 62. North America Levosimendan Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Levosimendan Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Levosimendan Sales by Type (2017-2022) & (Tons)
Table 65. Europe Levosimendan Sales by Type (2023-2028) & (Tons)
Table 66. Europe Levosimendan Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Levosimendan Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Levosimendan Sales by Application (2017-2022) & (Tons)
Table 69. Europe Levosimendan Sales by Application (2023-2028) & (Tons)
Table 70. Europe Levosimendan Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Levosimendan Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Levosimendan Sales by Country (2017-2022) & (Tons)
Table 73. Europe Levosimendan Sales by Country (2023-2028) & (Tons)
Table 74. Europe Levosimendan Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Levosimendan Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Levosimendan Sales by Type (2017-2022) & (Tons)
Table 77. Asia Pacific Levosimendan Sales by Type (2023-2028) & (Tons)
Table 78. Asia Pacific Levosimendan Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Levosimendan Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Levosimendan Sales by Application (2017-2022) & (Tons)
Table 81. Asia Pacific Levosimendan Sales by Application (2023-2028) & (Tons)
Table 82. Asia Pacific Levosimendan Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Levosimendan Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Levosimendan Sales by Region (2017-2022) & (Tons)
Table 85. Asia Pacific Levosimendan Sales by Region (2023-2028) & (Tons)
Table 86. Asia Pacific Levosimendan Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Levosimendan Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Levosimendan Sales by Type (2017-2022) & (Tons)
Table 89. Latin America Levosimendan Sales by Type (2023-2028) & (Tons)
Table 90. Latin America Levosimendan Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Levosimendan Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Levosimendan Sales by Application (2017-2022) & (Tons)
Table 93. Latin America Levosimendan Sales by Application (2023-2028) & (Tons)
Table 94. Latin America Levosimendan Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Levosimendan Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Levosimendan Sales by Country (2017-2022) & (Tons)
Table 97. Latin America Levosimendan Sales by Country (2023-2028) & (Tons)
Table 98. Latin America Levosimendan Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Levosimendan Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Levosimendan Sales by Type (2017-2022) & (Tons)
Table 101. Middle East and Africa Levosimendan Sales by Type (2023-2028) & (Tons)
Table 102. Middle East and Africa Levosimendan Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Levosimendan Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Levosimendan Sales by Application (2017-2022) & (Tons)
Table 105. Middle East and Africa Levosimendan Sales by Application (2023-2028) & (Tons)
Table 106. Middle East and Africa Levosimendan Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Levosimendan Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Levosimendan Sales by Country (2017-2022) & (Tons)
Table 109. Middle East and Africa Levosimendan Sales by Country (2023-2028) & (Tons)
Table 110. Middle East and Africa Levosimendan Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Levosimendan Revenue by Country (2023-2028) & (US$ Million)
Table 112. Tenax Therapeutics Corporation Information
Table 113. Tenax Therapeutics Description and Major Businesses
Table 114. Tenax Therapeutics Levosimendan Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. Tenax Therapeutics Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Tenax Therapeutics Recent Development
Table 117. Shengnuo Biotechnology Corporation Information
Table 118. Shengnuo Biotechnology Description and Major Businesses
Table 119. Shengnuo Biotechnology Levosimendan Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. Shengnuo Biotechnology Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Shengnuo Biotechnology Recent Development
Table 122. Olon Corporation Information
Table 123. Olon Description and Major Businesses
Table 124. Olon Levosimendan Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. Olon Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Olon Recent Development
Table 127. Melody Healthcare Corporation Information
Table 128. Melody Healthcare Description and Major Businesses
Table 129. Melody Healthcare Levosimendan Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 130. Melody Healthcare Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Melody Healthcare Recent Development
Table 132. Precise Group Corporation Information
Table 133. Precise Group Description and Major Businesses
Table 134. Precise Group Levosimendan Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 135. Precise Group Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Precise Group Recent Development
Table 137. Alven Laboratories Corporation Information
Table 138. Alven Laboratories Description and Major Businesses
Table 139. Alven Laboratories Levosimendan Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 140. Alven Laboratories Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Alven Laboratories Recent Development
Table 142. Fermion Corporation Information
Table 143. Fermion Description and Major Businesses
Table 144. Fermion Levosimendan Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 145. Fermion Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Fermion Recent Development
Table 147. Aspen Corporation Information
Table 148. Aspen Description and Major Businesses
Table 149. Aspen Levosimendan Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 150. Aspen Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Aspen Recent Development
Table 152. Enomark Corporation Information
Table 153. Enomark Description and Major Businesses
Table 154. Enomark Levosimendan Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 155. Enomark Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Enomark Recent Development
Table 157. Sirnaomics Corporation Information
Table 158. Sirnaomics Description and Major Businesses
Table 159. Sirnaomics Levosimendan Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 160. Sirnaomics Levosimendan Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Sirnaomics Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Levosimendan Distributors List
Table 165. Levosimendan Customers List
Table 166. Levosimendan Market Trends
Table 167. Levosimendan Market Drivers
Table 168. Levosimendan Market Challenges
Table 169. Levosimendan Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Levosimendan Product Picture
Figure 2. Global Levosimendan Market Share by Type in 2021 & 2028
Figure 3. Purity ≥99.5% Product Picture
Figure 4. Purity ≥99.9% Product Picture
Figure 5. Global Levosimendan Market Share by Application in 2021 & 2028
Figure 6. Injection Solution
Figure 7. Oral Liquid
Figure 8. Levosimendan Report Years Considered
Figure 9. Global Levosimendan Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 10. Global Levosimendan Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 11. Global Levosimendan Production Market Share by Region (2017-2022)
Figure 12. Global Levosimendan Production Market Share by Region (2023-2028)
Figure 13. Levosimendan Production Growth Rate in North America (2017-2028) & (Tons)
Figure 14. Levosimendan Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 15. Levosimendan Production Growth Rate in China (2017-2028) & (Tons)
Figure 16. Levosimendan Production Growth Rate in India (2017-2028) & (Tons)
Figure 17. Global Levosimendan Sales 2017-2028 (Tons)
Figure 18. Global Levosimendan Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Levosimendan Revenue 2017-2028 (US$ Million)
Figure 20. Global Levosimendan Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 21. Global Levosimendan Sales Market Share by Region (2017-2022)
Figure 22. Global Levosimendan Sales Market Share by Region (2023-2028)
Figure 23. North America Levosimendan Sales YoY (2017-2028) & (Tons)
Figure 24. North America Levosimendan Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Europe Levosimendan Sales YoY (2017-2028) & (Tons)
Figure 26. Europe Levosimendan Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Levosimendan Sales YoY (2017-2028) & (Tons)
Figure 28. Asia-Pacific Levosimendan Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Latin America Levosimendan Sales YoY (2017-2028) & (Tons)
Figure 30. Latin America Levosimendan Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Middle East & Africa Levosimendan Sales YoY (2017-2028) & (Tons)
Figure 32. Middle East & Africa Levosimendan Revenue YoY (2017-2028) & (US$ Million)
Figure 33. The Levosimendan Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 34. The Top 5 and 10 Largest Manufacturers of Levosimendan in the World: Market Share by Levosimendan Revenue in 2021
Figure 35. Levosimendan Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 36. Global Levosimendan Sales Market Share by Type (2017-2028)
Figure 37. Global Levosimendan Revenue Market Share by Type (2017-2028)
Figure 38. Global Levosimendan Sales Market Share by Application (2017-2028)
Figure 39. Global Levosimendan Revenue Market Share by Application (2017-2028)
Figure 40. North America Levosimendan Sales Market Share by Type (2017-2028)
Figure 41. North America Levosimendan Revenue Market Share by Type (2017-2028)
Figure 42. North America Levosimendan Sales Market Share by Application (2017-2028)
Figure 43. North America Levosimendan Revenue Market Share by Application (2017-2028)
Figure 44. North America Levosimendan Sales Share by Country (2017-2028)
Figure 45. North America Levosimendan Revenue Share by Country (2017-2028)
Figure 46. United States Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 47. Canada Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 48. Europe Levosimendan Sales Market Share by Type (2017-2028)
Figure 49. Europe Levosimendan Revenue Market Share by Type (2017-2028)
Figure 50. Europe Levosimendan Sales Market Share by Application (2017-2028)
Figure 51. Europe Levosimendan Revenue Market Share by Application (2017-2028)
Figure 52. Europe Levosimendan Sales Share by Country (2017-2028)
Figure 53. Europe Levosimendan Revenue Share by Country (2017-2028)
Figure 54. Germany Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 55. France Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 56. U.K. Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 57. Italy Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 58. Russia Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 59. Asia Pacific Levosimendan Sales Market Share by Type (2017-2028)
Figure 60. Asia Pacific Levosimendan Revenue Market Share by Type (2017-2028)
Figure 61. Asia Pacific Levosimendan Sales Market Share by Application (2017-2028)
Figure 62. Asia Pacific Levosimendan Revenue Market Share by Application (2017-2028)
Figure 63. Asia Pacific Levosimendan Sales Share by Region (2017-2028)
Figure 64. Asia Pacific Levosimendan Revenue Share by Region (2017-2028)
Figure 65. China Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 66. Japan Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 67. South Korea Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 68. India Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 69. Australia Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 70. China Taiwan Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 71. Indonesia Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 72. Thailand Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 73. Malaysia Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Levosimendan Sales Market Share by Type (2017-2028)
Figure 75. Latin America Levosimendan Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Levosimendan Sales Market Share by Application (2017-2028)
Figure 77. Latin America Levosimendan Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Levosimendan Sales Share by Country (2017-2028)
Figure 79. Latin America Levosimendan Revenue Share by Country (2017-2028)
Figure 80. Mexico Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Levosimendan Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Levosimendan Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Levosimendan Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Levosimendan Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Levosimendan Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Levosimendan Revenue Share by Country (2017-2028)
Figure 89. Turkey Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 91. UAE Levosimendan Revenue (2017-2028) & (US$ Million)
Figure 92. Levosimendan Value Chain
Figure 93. Levosimendan Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
世界のレボシメンダン市場予測（～2028年）：純度≥99.5％、純度≥99.9％ The Levosimendan market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recen…- グルコン酸カルシウム経口液剤のグローバル市場インサイト・予測（～2028年） Calcium gluconate oral solution is indicated for the prevention and treatment of calcium deficiency, such as osteoporosis, hand and foot convulsions, bone hypoplasia, rickets and calcium supplementation in children, pregnant and lactating women, menopausal women and the elderly. Market Analysis and …
- 世界のグルコン酸カルシウム経口液剤市場予測（～2028年）：大人用、子供用 The Calcium Gluconate Oral Liquid market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 高純度MDIのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global High Purity MDI Market Due to the COVID-19 pandemic, the global High Purity MDI market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully consi…
- 注入用ヒアルロン酸のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Injection Grade Hyaluronic Acid Market The global Injection Grade Hyaluronic Acid market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Purity…